Skip to content

Effect of ciprofloxacin on advanced chronic periodontitis

Evaluation the effect of adjuvant therapy with ciprofloxacin in non-surgical treatment of sever chronic periodontitis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017061734582N1
Enrollment
80
Registered
2017-07-23
Start date
2017-06-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sever chronic periodontitis. Chronic periodontitis Chronic pericoronitis

Interventions

Intervention 1: In this study, for the case group, ciprofloxacin 500 milligrams of daroo pakhsh company were given two days daily for 7 days. Intervention 2: In this study, for the control group, plac
Treatment - Drugs
In this study, for the case group, ciprofloxacin 500 milligrams of daroo pakhsh company were given two days daily for 7 days
In this study, for the control group, placebo 500 milligrams of daroo pakhsh company were given two days daily for 7 days

Sponsors

zahdan university of medical siences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria :Age upper 18 years old? Presence of twenty teeth of least?Affection with spread mean to severe chronic periodontitis At least (3-5 min clinical attachment loss in more thou 30 percent of the mouth areas . Exclusion criteria: Lack of patient’s coloration? Antibiotic therapy doing the third past months?Allergy background for ciprofloxacin? Smoking people or addicted to tobacco? Affection with systemic diseases , which are effective on the periodontal conditions such as diabetes , blood disorders and immune system? Pregnant women? Periodical Intervention Performance during the third past months?People who are under treatment with warfarin , antacid T and Cyclosporine.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Gingival bleeding index(GBI). Timepoint: the first, scond and fourth months. Method of measurement: bleeding-non bleeding.;Probing depth(PD). Timepoint: the first, scond and fourth months. Method of measurement: Based on Periodontal Probe williams.;Clinical attachment level(CAL). Timepoint: the first, scond and fourth months. Method of measurement: Based on Periodontal Probe williams.;Drug. Timepoint: First month for 7 days, two capsules a day. Method of measurement: Based on the presence or absence of consumption.;Time. Timepoint: the first, scond and fourth months. Method of measurement: Based on the onset of a therapeutic intervention.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactdr.masood bamedi

dentistry zahdan university

e.kalvand@zaums.ac.ir+98 54 3342 9519

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026